Medius Holdings Co., Ltd.

TSE:3154 Stock Report

Market Cap: JP¥19.6b

Medius Holdings Past Earnings Performance

Past criteria checks 2/6

Medius Holdings has been growing earnings at an average annual rate of 3.9%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 4.1% per year. Medius Holdings's return on equity is 5.7%, and it has net margins of 0.4%.

Key information

3.9%

Earnings growth rate

3.8%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate4.1%
Return on equity5.7%
Net Margin0.4%
Next Earnings Update07 Feb 2025

Recent past performance updates

Medius Holdings' (TSE:3154) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Oct 04
Medius Holdings' (TSE:3154) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Recent updates

Medius Holdings' (TSE:3154) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Oct 04
Medius Holdings' (TSE:3154) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Medius Holdings (TSE:3154) Has A Somewhat Strained Balance Sheet

Aug 02
Medius Holdings (TSE:3154) Has A Somewhat Strained Balance Sheet

Optimistic Investors Push Medius Holdings Co., Ltd. (TSE:3154) Shares Up 26% But Growth Is Lacking

Jun 04
Optimistic Investors Push Medius Holdings Co., Ltd. (TSE:3154) Shares Up 26% But Growth Is Lacking

Revenue & Expenses Breakdown

How Medius Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:3154 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24268,7921,11229,5170
30 Jun 24259,7891,12428,6710
31 Mar 24250,78284827,9950
31 Dec 23247,4631,14427,4920
30 Sep 23240,4441,27626,8510
30 Jun 23239,0541,49826,3270
31 Mar 23234,2711,12026,2030
31 Dec 22232,6191,29725,7340
30 Sep 22230,8181,54125,2190
30 Jun 22226,6061,86724,4760
31 Mar 22232,0852,43023,4620
31 Dec 21241,3002,54322,9080
30 Sep 21247,0032,48222,3480
30 Jun 21246,7872,06522,0590
31 Mar 21238,5131,98922,2020
31 Dec 20223,0531,33421,6760
30 Sep 20209,80581921,1830
30 Jun 20210,38895120,6940
31 Mar 20208,7281,32619,3600
31 Dec 19207,08713419,1800
30 Sep 19208,12422519,0330
30 Jun 19197,691-7018,7940
31 Mar 19189,707-25318,0580
31 Dec 18180,90983517,2360
30 Sep 18172,48778216,4570
30 Jun 18168,13574115,7730
31 Mar 18165,73377615,6290
31 Dec 17164,60682415,5060
30 Sep 17163,83886315,3340
30 Jun 17162,65486315,1650
31 Mar 17161,66089214,9620
31 Dec 16162,89291814,8240
30 Sep 16160,70896914,7100
30 Jun 16158,40089914,6270
31 Mar 16156,12173314,5260
31 Dec 15150,31649514,3970
30 Sep 15148,87841314,2670
30 Jun 15146,16843314,1130
31 Mar 15142,29548413,8980
31 Dec 14147,65673513,6350
30 Sep 14147,24680313,3720
30 Jun 14145,96996813,0400
31 Mar 14146,3391,03112,8610

Quality Earnings: 3154 has high quality earnings.

Growing Profit Margin: 3154's current net profit margins (0.4%) are lower than last year (0.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 3154's earnings have grown by 3.9% per year over the past 5 years.

Accelerating Growth: 3154's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 3154 had negative earnings growth (-12.8%) over the past year, making it difficult to compare to the Healthcare industry average (8.3%).

Return on Equity

High ROE: 3154's Return on Equity (5.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 13:34
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medius Holdings Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution